MicroPort EP(SH:688351) Sou Hu Cai Jing·2025-08-19 12:05Group 1 - The company, Microelectrophysiology, closed at 26.68 yuan on August 19, with a 3.81% increase, and a rolling PE ratio of 190.90, marking a new low in 316 days, with a total market value of 12.556 billion yuan [1] - In the medical device industry, the average PE ratio is 59.49, and the median is 40.19, placing Microelectrophysiology at the 111th position in the industry ranking [1] - As of the first quarter of 2025, seven institutions hold shares in Microelectrophysiology, all of which are funds, with a total holding of 1.6693 million shares valued at 0.033 billion yuan [1] Group 2 - Shanghai Microelectrophysiology Medical Technology Co., Ltd. focuses on the development, production, and sales of innovative medical devices in the field of electrophysiological interventional diagnosis and ablation treatment [2] - The company's main products include the Columbus 3D cardiac electrophysiology mapping system and various types of disposable electrophysiology catheters, which have received approval for inclusion in the 2024 Shanghai "New and Excellent Drug and Device" product catalog [2] - The project "Research and Application of High Precision Intracardiac Interventional Navigation System" won an award at the 2024 Shanghai Second Young and Middle-aged Engineer Innovation and Entrepreneurship Competition [2] Group 3 - The latest performance report for the first quarter of 2025 shows that the company achieved an operating income of 104 million yuan, a year-on-year increase of 16.77%, and a net profit of 17.8705 million yuan, a year-on-year increase of 328.63%, with a gross profit margin of 60.56% [3] - The PE ratio (TTM) for Microelectrophysiology is 190.90, while the industry average is 59.49, indicating a significant premium [3] - The total market value of Microelectrophysiology is 12.556 billion yuan, compared to the industry median market value of 5.918 billion yuan [3]